Aller au contenu principal
Profil bibliographique

Carolina Abrutzky

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

5Publications signalées
36Citations signalées
0Affiliations récentes

Les domaines associés

Food Allergy and Anaphylaxis ResearchAllergic Rhinitis and SensitizationAsthma and respiratory diseasesOpioid Use Disorder TreatmentForensic Toxicology and Drug Analysis

Les publications récentes

Accès ouvert 2025 article OpenAlex

First-in-class intranasal epinephrine spray for anaphylaxis: Dose finding clinical study

Tair Lapidot, Yuval Tal, Dalia Megiddo, Galia Temtsin Krayz et autres

Background Anaphylaxis is a life-threatening clinical presentation of acute systemic allergic reactions. Timely administration of epinephrine, usually by intramuscular autoinjector, is a robust life-saving treatment. Despite the critical necessity, there are multiple deterrents to patients' proper use of epinephrine autoinjectors. FMXIN002 is …

il (code pays fourni par la source)

1 citation Journal of Allergy and Clinical Immunology Global
Accès ouvert 2023 article OpenAlex

Fast Acting, Dry Powder, Needle-Free, Intranasal Epinephrine Spray: A Promising Future Treatment for Anaphylaxis

Yuval Tal, Yaarit Ribak, Limor Rubin, Aviv Talmon et autres

BACKGROUND: Epinephrine intramuscular (IM) autoinjector is a life-saving drug for the emergency treatment of immediate-type allergic reactions (type I). Nevertheless, it is sometimes applied incorrectly or underused because of short shelf life, high costs, fear of use, or inconvenience of carrying. FMXIN002, …

il, ca, us (code pays fourni par la source)

19 citations The Journal of Allergy and Clinical Immunology In Practice
Accès ouvert 2022 article OpenAlex

A Novel Faster-Acting, Dry Powder-Based, Naloxone Intranasal Formulation for Opioid Overdose

Tair Lapidot, Mohammed Bouhajib, Janice Faulknor, Shabaz Khan et autres

OBJECTIVE: To examine the pharmacokinetics and safety of FMXIN001, a new intranasal powder-based naloxone formulation, in comparison to Narcan® nasal liquid spray. METHODS: FMXIN001, was developed by blending drug microspheres with larger lactose monohydrate particles, that serve as diluent and carrier, as …

us, ca, il (code pays fourni par la source)

15 citations Pharmaceutical Research

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.